Medi-Physics expands radiopharmacy reach

Article

Radiopharmacy firm Medi-Physicsof Arlington Heights, IL, has signed on Mallinckrodt Medical andGeodax Technologies as distributors in an effort to expand itspharmacy network to appeal to managed-care providers and grouppurchasers. Mallinckrodt, which

Radiopharmacy firm Medi-Physicsof Arlington Heights, IL, has signed on Mallinckrodt Medical andGeodax Technologies as distributors in an effort to expand itspharmacy network to appeal to managed-care providers and grouppurchasers. Mallinckrodt, which runs 35 radiopharmacies, and Geodax,which has five sites, will bring the total number of radiopharmaciesselling Medi-Physics products to 63 when the network becomes effectiveJan. 16. Medi-Physics products include brain SPECT agent Ceretecand bone pain therapeutic Metastron.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
FDA Clears Gleamer’s ChestView AI Software for CXR

FDA Clears Gleamer’s ChestView AI Software for CXR

Jeff Hall
March 25th 2025
Article

Adjunctive use of the AI-powered software led to an average 38.6 percent increase in the detection of pneumothorax by general radiologists, according to a 2023 study.

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

Could Microultrasonography-Guided Biopsy be an Alternative to MRI for PCa Detection in Biopsy-Naïve Men?

Could Microultrasonography-Guided Biopsy be an Alternative to MRI for PCa Detection in Biopsy-Naïve Men?

Jeff Hall
March 24th 2025
Article

Microultrasonography-guided biopsy offered comparable detection as MRI/conventional ultrasound-guided biopsy in detection of Gleason grade group 2 or higher prostate cancer, according to a new international multicenter study.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?

Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?

Jeff Hall
March 21st 2025
Article

Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.

PSMA PET Prep Product Gozellix Garners FDA Approval

PSMA PET Prep Product Gozellix Garners FDA Approval

Jeff Hall
March 21st 2025
Article

Indicated for use in cases involving suspected metastasis with PCa or suspected PCa recurrence due to elevated PSA level, Gozellix reportedly has a longer shelf life than other gallium-based PET imaging products.

© 2025 MJH Life Sciences

All rights reserved.